A detailed history of Knott David M Jr transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Knott David M Jr holds 1,000,000 shares of XERS stock, worth $2.92 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
1,000,000
Previous 820,000 21.95%
Holding current value
$2.92 Million
Previous $1.85 Million 54.47%
% of portfolio
1.0%
Previous 0.74%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.06 - $2.96 $370,800 - $532,800
180,000 Added 21.95%
1,000,000 $2.85 Million
Q2 2024

Aug 12, 2024

BUY
$1.7 - $2.45 $374,000 - $539,000
220,000 Added 36.67%
820,000 $1.85 Million
Q1 2024

May 14, 2024

BUY
$2.04 - $3.22 $432,663 - $682,929
212,090 Added 54.68%
600,000 $1.33 Million
Q4 2023

Feb 13, 2024

BUY
$1.47 - $2.36 $570,227 - $915,467
387,910 New
387,910 $912,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $397M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.